ZACKS INVESTMENT MANAGEMENT Neurocrine Biosciences, Inc. Transaction History

ZACKS INVESTMENT MANAGEMENT portfolio value:

$5.13M
portfolio value

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 48.37K shares 5.13M $106.21 48.37K